CN108497392A - 一种预防高血糖高血压的食品 - Google Patents
一种预防高血糖高血压的食品 Download PDFInfo
- Publication number
- CN108497392A CN108497392A CN201810531212.0A CN201810531212A CN108497392A CN 108497392 A CN108497392 A CN 108497392A CN 201810531212 A CN201810531212 A CN 201810531212A CN 108497392 A CN108497392 A CN 108497392A
- Authority
- CN
- China
- Prior art keywords
- food
- mass fraction
- ultramicro powder
- cassia tree
- chinese cassia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 42
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 19
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 30
- 241000522254 Cassia Species 0.000 claims abstract description 27
- 230000000694 effects Effects 0.000 claims abstract description 27
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 26
- 239000003826 tablet Substances 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000006187 pill Substances 0.000 claims abstract description 4
- 239000002245 particle Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 235000019082 Osmanthus Nutrition 0.000 claims description 3
- 241000333181 Osmanthus Species 0.000 claims description 3
- 235000015179 biltong Nutrition 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000005550 wet granulation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000005374 membrane filtration Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 9
- 230000002265 prevention Effects 0.000 abstract description 7
- 239000000470 constituent Substances 0.000 abstract description 4
- 230000001077 hypotensive effect Effects 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000010534 mechanism of action Effects 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 241000208340 Araliaceae Species 0.000 description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 description 8
- 235000008434 ginseng Nutrition 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 150000002515 isoflavone derivatives Chemical class 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 208000017701 Endocrine disease Diseases 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000009045 body homeostasis Effects 0.000 description 2
- 108010089934 carbohydrase Proteins 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000030172 endocrine system disease Diseases 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000045500 Diseae Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种预防高血糖高血压的食品,其包含质量分数80~90%的肉桂超微细粉末、10~15%的向天果超微细粉末。该食品的剂型可为片剂、胶囊剂或丸剂。向天果和肉桂分别具有不同的降血糖和降血压活性成分,这些活性成分具有不同的作用机制,对人体的多个方面进行干扰,针对多种不同原因引起的高血糖高血压都具有一定的预防和调节作用,更重要地是,本发明通过组配可抵消和中和单独服用其中一种时,给人体带来的燥热或寒凉等问题。
Description
技术领域
本发明涉及一种预防高血糖高血压的食品。
背景技术
世界各国糖尿病的发病率正在逐年增加,据世界卫生组织有关资料 表明,全球糖尿病患者已经超过1亿,我国糖尿病患者约3000万人。糖 尿病患者的康复医疗已经成为我国医疗卫生工作的重要内容之一。高血 糖及糖尿病的发病率有先天遗传和后天因素等多种原因,但主要原因之 一是近年来中国人的膳食中能量、蛋白质和脂肪的来源明显发生变化。 目前各种化学合成药物对高血糖高血压的控制有明显的作用,但是这些 药物的长期服用导致患者生活水平低,药物在体内的积累还会对肝脏和 肾脏造成很大负担,导致肝功能、肾功能退化。
中医养生学自古以来提倡的是未病先治,即所谓未病先防,就是在 没得病的时候做好预防工作,避免得病,只有这样才可以真正提高人们 的生活质量和身体素质,享受愉快的家庭生活。未病先治的途径包括(1) 减少不良的精神刺激。(2)调节饮食,劳逸适度。(3)锻炼身体是增 强体质。而这三者又是相辅相成的,饮食调节好了,身体舒服,情绪自 然舒畅,情绪的舒畅也会让人更愿意参与锻炼。而饮食的最佳境界是药 食同源,也就是日常摄入的食品因含有一些特殊成分,在满足摄入能量 和各种矿物质及维生素的同时,还能预防一些慢性疾病,同时由于这些 食物来自于纯天然,无任何化学试剂残留,也不会有任何肝肾毒害作用。
人参属于卫生部批准的药食两用品,有研究表明人参对血糖和血压 具有调节作用,但人参价格昂贵、药源逐年匮乏,同时单纯用人参的效 果有限、人参的副作用(人参滥用综合征:助火、做饱、高血压、神经 衰弱、失眠等中枢神经兴奋和激动状态)无法被中和抵消,且口感也不 好。而其他类的具有预防作用的食品,用到的食品原料复杂,通常在3~8种以上,里面往往还会掺入一些中药,同样存在口感很不好的问题。作 为日常食品来说,口感决定了消费者是否愿意长期食用的一个根本因素。
发明内容
为了解决现有技术的上述问题,本发明的提供一种预防高血糖高血 压的食品,包含向天果和肉桂,两种原料都来自天然食品,分别具有不 同类型的降血糖和降血压活性成分,这些活性成分具有不同的作用机制, 对人体的多个方面进行干扰,针对多种不同原因引起的高血糖高血压都 具有一定的预防和调节作用,同时还通过组配抵消单独使用所存在的副 作用。
为了达到上述目的,本发明采用的主要技术方案包括:
一种预防高血糖高血压的食品,其包含质量分数80~90%的肉桂超微 细粉末、10~15%的向天果超微细粉末。
优选地,所述超微细粉末粒径为1nm~1μm。
优选地,所述食品为胶囊剂、片剂或丸剂。
优选地,所述食品由质量分数87.5%的肉桂超微细粉末和质量分数 12.5%的向天果超微细粉末装胶囊制成。
优选地,所述食品由质量分数80~85%的肉桂超微细粉末和质量分数 10~20%的向天果超微细粉末和质量分数3~6%的麦芽糊精制粒、压片制 成。
优选地,所述食品由质量分数80~85%的肉桂超微细粉末和质量分数 10~20%的向天果超微细粉末,湿法制粒后直接压片制成。因为一些糖尿 病患者不适合摄入麦芽糊精等成分,因此可直接湿法制粒并压片。
优选地,所述肉桂超微细粉末和向天果超微细粉末是将干肉桂和向 天果按照预定比例混合,再使用破壁机每分钟45000转破碎10~40min得 到超微细粉末。
优选地,在使用破壁机破碎后,加去离子水形成悬浮液,悬浮液再 经超微膜分离过滤处理,滤液浓缩干燥,得到要1nm~100nm的功效粒子。
优选地,所述破壁机为真空破壁机,结合“抽真空“技术进行全面升级 的更好的破壁机,也就是真空破壁机。其不仅涵盖破壁机所具备的所有 热饮、冷饮功能,而且将“高速破壁技术“与“抽真空技术”相结合,能够在 食材破壁前快速抽走杯内空气,让食材在真空状态下破壁,隔绝空气, 延缓氧化,让食材的营养保留更完整。
使用一些家用破壁机和工业破壁机都可以实现本发明目的,常见的 品牌有国外原厂进口的破壁机品牌有NOVIS,Vitamix,Blendtec;国 内的品牌有九阳,美的,奥克斯等等。
超微膜分离过滤,即微滤技术。基本原理是筛孔分离,在压力差的 推动下,原料液中的溶剂和小的溶质粒子透过微孔膜(孔径1~100nm), 而大的粒子组分被膜截留。
本发明的技术效果:
(1)肉桂和向天果都具有很高的预防高血糖高血压的功效:
其中,肉桂富含强活性的天然HDL化糖酶,不仅能替代胰岛素打开 葡萄糖进入细胞的通道,将血糖转化为能量,还能清除血液及五脏中的 糖毒,利于消除糖尿病并发症,修复胰岛β细胞,恢复胰脏功能,益于 控制糖尿病。相关研究和报道也证实了肉桂对肾上腺皮质性高血压有降 压作用;对肾性高血压,则无作用。
向天果富含以下三大活性成分,因而拥有高效的改善高血压和血糖 水平的功能:①皂甙:皂甙可抑制胆固醇在肠道的吸收,能降低血浆胆 固醇,改善脂质代谢,并可预防因高脂肪膳食所造成的高血脂症;降低 血糖并改善症状;能调节机体的溶血系统,抑制血小板聚集,改善血凝, 减少和避免血栓的形成,增加心脑血流量,提高机体抗缺氧功能;改善血凝状况避免心肌梗塞;增加白血环数量加吞噬细胞的吞噬能力;提高 免疫功能;抗癌抑制肿瘤。②黄酮类:有效促进血液循环,预防脑血管 阻塞引起中风、预防老人痴呆症;能降低脂肪在血管壁上的累积;能改 善或降低血中胆固醇含量;能促使体内防止各组织发炎的自然抗体生成; 能阻挠动脉硬化的形成;能清除体内过多的自由基;具有防止体内氧化 作用的功能。③异黄酮:是一种天然植物雌激素,可调理女性生理时钟, 舒缓更年期症状,预防骨骼疏松症。
可见其将血压功能主要是通过其所含的皂苷和黄酮类,抑制胆固醇 的吸收,降低血浆胆固醇,清理血管壁,从而促进血液循环、防止血管 阻塞,能够帮助预防心脏病和中风,从表观上起到降血压作用,与肉桂 对肾上腺皮质性高血压的降压作用形成功能互补,扩大本发明食品的适 用人群。
(2)副作用互补中和抵消:
肉柱为辛热药,本草有“小毒”之记载,用量不宜过大。曾有报道, 顿服肉桂末1.2两后,发生头晕、眼花、眼胀、眼涩、咳嗽、尿少、干渴、 脉数大等毒性反应,经换服寒凉药后1~2周才逐渐消除。本品甘热助阳 补火。可见肉桂性热,适合天凉时节食用,夏季忌食桂皮,具有除积冷、 暖脾胃,通血脉的作用。而向天果性凉,解热、收敛,无任何副作用, 为非常难得的一种植物。《马来西亚草药目录》中记载,向天果味苦、 涩、性凉,解热、收敛。
将性热的肉桂与性凉的向天果组配服用,使肉桂的“小毒”被向天 果中和抵消,防止服用者出现头晕、眼花、眼胀、眼涩、咳嗽、尿少、 干渴、脉数大等反应。肉桂与向天果二者的组配实现了各自互助互补、 扬长避短、相得益彰的功效,共同实现良好的降血糖降血压效果。
(3)向天果一种即可相当于多种传统中草药的组配
向天果所富含的三大活性成分,皂甙、黄酮类、异黄酮等,虽然以 上三种活性成份个别都能在不同的药用植物中获取,例如:皂甙可以在 久负盛名的人参中找到,而黄酮化合物也可以从银杏中获取。但是同一 植物中同时获取这三种成份,且含量比如此合适的天然食物却不多见。 这三种活性成份在保健上的应用范围已相当广阔,向来备受医学家们的重视,如今发现竟同在一植物体内善巧配搭,功效显而易见,再配合向 天果中原有的其他营养成份,更能发挥其功能。
因而,应用向天果制作本发明的食品,相较于替换成人参、银杏叶 和大豆等混合的方式而言,本发明的食品具有功效活性成分含量比更高、 杂质更少、预防高血糖高血压的效果更明显等特点,从生产制造者角度 来说,也更易制造生产。
总之,向天果对人体可实现全面性的调节,直接或间接地涵养了人 体的五脏六腑,尤其是对物质循环系统及免疫系统更有明显的效果。其 有助于调节人体各器官之间的内环境平衡,保障细胞的正常活动,促进 微循环系统的血液流量,提高人体免疫能力,确保人体器官组织功能操 作健全,对治疗糖尿病,高血压、高血脂、过敏性疾病、内分泌失调等有非常显著的功效。
具体实施方式
为了更好的解释本发明,以便于理解,下面结合实施方式,对本发 明作详细描述。
实施例
本发明的食品为片剂。生产制作流程为
(1)、破壁制粉
取87.5质量份的干肉桂、12.5质量份的干向天果混合后,放入破壁 机45000转速下破壁30min,得到混合超微细粉末。
(2)、制粒
将超微细粉末中加入总质量1%的麦芽糊精,用去离子水喷洒物料, 放入制粒机搅拌制粒,以800-1000转/分钟制粒30分钟。
(3)、压片
调整压片厚度,将制粒好的物料送入压片机压片。
(4)干燥、包装,制得每片1g的片剂。
按照每片1g~2g,早晚空腹各吃一片,即可达到好的预防的效果。
此外,由于向天果有一些苦味,可通过包糖衣将片剂制成糖衣片, 以改善口感,或者掺入木糖醇等,通过木糖醇的甜味和黏合作用,制成 丸药。此外,还可以装胶囊制成胶囊剂。
据发明人及周围亲朋好友约20多人,按照上述剂量和服用方法服用 约3个月后,均反馈良好。一些中老年轻微高血压患者,经过测量,其 血压值有下降趋势;个别糖尿病患者在停药一段时间后,连续服用本发 明的辅助食品30天,同时严格控制饮食糖的摄入量,其血糖值也稳定在 停药时的水平。由此说明,本发明的食品,确实在降血糖降血压方面具有预防和调节的功效。
因此,本发明的食品,可作为降血糖药物的辅助食品。高血糖患者 在通过药物干涉,将血糖值维持到正常的情况下,便可以停止服用降糖 药物,而坚持服用本发明的辅助食品,来稳固血糖值。由于它没有副作 用,能预防或减少并发症,同时向天果本身具有的保肝作用。通过本发 明食品的辅助作用,减少西药降血糖药物的摄入量,从而减少对肝肾脏的损害。
此外,这20名服用者普遍认为自身的免疫力也有明显增强,服用长 达半年,均未出现头晕、眼花、眼胀、眼涩、咳嗽、尿少、干渴等反应, 这说明通过肉桂的“小毒性”确实可被向天果抵消,同时由于向天果属 于寒凉性质,通过肉桂的配合作用,也可以防止因性寒凉食物对寒性体 质的人群带来的诸如“脾胃虚寒”等问题。
在降血糖方面:向天果降血糖的原理是它能调整身体代谢功能,使 自身的胰岛素得以“复活”而充分发挥作用,这样就可使血糖能够重新被机 体组织细胞所摄取和利用,使血糖下降,达到长期稳定和全面地控制血 糖的目的,使人体可长久享用自身分泌的胰岛素,以分解血糖。肉桂的 降血糖是通过其富含的强活性的天然HDL化糖酶,替代胰岛素打开葡萄 糖进入细胞的通道,将血糖转化为能量,还能清除血液及五脏中的糖毒, 利于消除糖尿病并发症。因此,肉桂和向天果在降血糖方面具有不同的 机制和原理,故能从人体机能的多角度、多方面共同实现降血压作用。
在降血压方面:肉桂是通过抑制肾上腺皮质激素来控制高血压,而 向天果是通过其所含的皂苷抑制胆固醇经肠道吸收进血管、加速血脂代 谢、降低血脂含量、增进血液循环和防止血管阻塞等“表症”方面辅助 降低血压,预防脑血管阻塞引起中风、预防老人痴呆症,预防心脏病。 因此,可与肉桂形成作用互补,增进本发明食品的功效、扩大可适用的 人群。
在其他方面:向天果内还含有天然雌激素(异黄酮)、多种天然蛋 白质、维生素A、B1、B3、B6、D、E、叶酸、铁及钾等人体必要营养成 份。这些成分有助于调节人体各器官之间的内环境平衡,保障每个细胞 的正常活动,促进微循环,提高人体免疫能力,确保人体器官组织功能 操作健全。对预防过敏性疾病、内分泌失调等有非常显著的功效。向天 果还具有养生作用,对于壮阳益精,消除疲劳,增强体力,排毒,修复组 织,提高受孕率,扶正固体,活化细胞,美艳养颜,预防细胞老化、强 胃健肺,解酒保肝,益血补脉、健睥止泻,清毒排毒,养心安神等功效。
Claims (8)
1.一种预防高血糖高血压的食品,其包含质量分数80~90%的肉桂超微细粉末、10~15%的向天果超微细粉末。
2.根据权利要求1所述的食品,其特征在于,所述食品为胶囊剂、片剂或丸剂。
3.根据权利要求1所述的食品,其特征在于,所述食品由质量分数87.5%的肉桂超微细粉末和质量分数12.5%的向天果超微细粉末装胶囊制成。
4.根据权利要求1所述的食品,其特征在于,所述食品由质量分数80~85%的肉桂超微细粉末和质量分数10~20%的向天果超微细粉末和质量分数3~6%的麦芽糊精制粒、压片制成。
5.根据权利要求1所述的食品,其特征在于,所述食品由质量分数80~85%的肉桂超微细粉末和质量分数10~20%的向天果超微细粉末,湿法制粒后直接压片制成。
6.根据权利要求1所述的食品,其特征在于,所述肉桂超微细粉末和向天果超微细粉末是将干肉桂和向天果按照预定比例混合,再使用破壁机每分钟45000转破碎10~40min得到超微细粉末。
7.根据权利要求6所述的食品,其特征在于,在使用破壁机破碎后,加去离子水形成悬浮液,悬浮液再经超微膜分离过滤处理,滤液浓缩干燥,得到要1nm~100nm的功效粒子。
8.根据权利要求1所述的食品,其特征在于,所述超微细粉末粒径为1nm~1μm。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810531212.0A CN108497392A (zh) | 2018-05-29 | 2018-05-29 | 一种预防高血糖高血压的食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810531212.0A CN108497392A (zh) | 2018-05-29 | 2018-05-29 | 一种预防高血糖高血压的食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108497392A true CN108497392A (zh) | 2018-09-07 |
Family
ID=63401969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810531212.0A Withdrawn CN108497392A (zh) | 2018-05-29 | 2018-05-29 | 一种预防高血糖高血压的食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108497392A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113142573A (zh) * | 2021-05-14 | 2021-07-23 | 刘爱华 | 一种降糖、脂、血粘的纯天然植物压片糖果及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1846758A (zh) * | 2005-04-04 | 2006-10-18 | 湖北省应城市人民医院 | 一种治疗糖尿病的降糖药物及其制备方法 |
CN104000877A (zh) * | 2014-05-30 | 2014-08-27 | 金鑫 | 一种降糖组合物及其应用 |
CN104705444A (zh) * | 2015-04-09 | 2015-06-17 | 宁德市畲家金闽红茶叶有限公司 | 一种降三高绿茶及其制备方法 |
CN105343181A (zh) * | 2015-11-25 | 2016-02-24 | 苏州普罗达生物科技有限公司 | 一种向天果超微破壁粉碎方法 |
CN106729123A (zh) * | 2017-03-29 | 2017-05-31 | 贵州穗蓝酒业科技有限公司 | 一种降三高的组合物及其制备方法 |
-
2018
- 2018-05-29 CN CN201810531212.0A patent/CN108497392A/zh not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1846758A (zh) * | 2005-04-04 | 2006-10-18 | 湖北省应城市人民医院 | 一种治疗糖尿病的降糖药物及其制备方法 |
CN104000877A (zh) * | 2014-05-30 | 2014-08-27 | 金鑫 | 一种降糖组合物及其应用 |
CN104705444A (zh) * | 2015-04-09 | 2015-06-17 | 宁德市畲家金闽红茶叶有限公司 | 一种降三高绿茶及其制备方法 |
CN105343181A (zh) * | 2015-11-25 | 2016-02-24 | 苏州普罗达生物科技有限公司 | 一种向天果超微破壁粉碎方法 |
CN106729123A (zh) * | 2017-03-29 | 2017-05-31 | 贵州穗蓝酒业科技有限公司 | 一种降三高的组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113142573A (zh) * | 2021-05-14 | 2021-07-23 | 刘爱华 | 一种降糖、脂、血粘的纯天然植物压片糖果及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105248820B (zh) | 辣木叶与红糖的组合物及其制备方法和应用 | |
EP2011500B1 (en) | Fat accumulation inhibitor for the treatment of metabolic syndrome | |
CN103156017A (zh) | 一种减肥降脂的黑茶饮料及其制备方法 | |
CN104904977A (zh) | 一种橙子、西柚复方压片糖果及其制备方法 | |
CN107865100A (zh) | 一种人参姜汁保健乳饮品及其制备方法 | |
CN103263054B (zh) | 一种降血压功能性饮品 | |
CN103122295A (zh) | 蓝莓红豆酒的制备工艺 | |
US20180296615A1 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
CN103891962A (zh) | 一种美容瘦身的保健茶及其制备方法 | |
CN103404852A (zh) | 一种营养性复方纳豆保健品 | |
CN103749827B (zh) | 一种高丽红参无花果茶的制备方法 | |
CN103156013A (zh) | 一种减肥降脂速溶黑茶及其制备方法 | |
CN1097552A (zh) | 一种添加银杏、葛根提取物的保健茶 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN108497392A (zh) | 一种预防高血糖高血压的食品 | |
CN102048215B (zh) | 一种保健饮料及其制备方法 | |
CN108771246A (zh) | 提高术后或化疗后患者的免疫力和恢复生理机能的组合物 | |
CN101574509A (zh) | 容颜不老制剂 | |
CN110679685A (zh) | 一种新型治疗高血压的益生菌健康茶及其制备方法 | |
CN109645484A (zh) | 一种用于老年慢性病的营养配方食品 | |
KR101147913B1 (ko) | 혈당 조절용 조성물 | |
JPS59106276A (ja) | 健康食品 | |
KR20050086788A (ko) | 파파야 퓌레 및 그의 용도 | |
CN107581609A (zh) | 一种大蒜多肽组合物 | |
CN106722059A (zh) | 一种具增强体质和抗癌功效的强化营养米及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180907 |
|
WW01 | Invention patent application withdrawn after publication |